These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21426837)

  • 21. [Toxicity research status of benzalkonium chloride on ocular surface].
    Huang C; Chen W; Chen Y; Liu Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):303-6. PubMed ID: 24931157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of topical travoprost with sofzia preservative for Japanese glaucoma patients.
    Kanamoto T; Kiuchi Y; Suehiro T; Nakano T; Nakano Y; Hirota A; Miyata A
    Hiroshima J Med Sci; 2010 Dec; 59(4):71-5. PubMed ID: 21361083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of glaucoma in patients with dry eye syndrome].
    Labbé A; Baudouin C
    J Fr Ophtalmol; 2010 Apr; 33(4):285-90. PubMed ID: 20304521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
    Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
    J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glaucoma and dry eye. Current concepts and future perspectives].
    Steven P; Cursiefen C
    Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Surface Disease and Glaucoma Medications: A Clinical Approach.
    Zhang X; Vadoothker S; Munir WM; Saeedi O
    Eye Contact Lens; 2019 Jan; 45(1):11-18. PubMed ID: 30199425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of preservatives in anti-glaucoma agents on the ocular surface].
    Potop V
    Oftalmologia; 2009; 53(2):92-6. PubMed ID: 19697847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
    Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments].
    Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
    J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops.
    Lajmi H; Chelly Z; Choura R; Mansour KB; Hmaied W
    J Fr Ophtalmol; 2021 Nov; 44(9):1326-1331. PubMed ID: 34325926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium].
    Seino S; Takada Y; Saika S
    Yakugaku Zasshi; 2021; 141(1):35-39. PubMed ID: 33390445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
    Kahook MY; Noecker R
    Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.